Science & Technology
B-Smart - Broadly Neutralizing Antibodies for Sarna Mediated Antiviral Response Therapy
Department of Health and Human Services — National Institutes of Health
Opportunity #: 75N93025C00022
Award Ceiling
$600K
Award Floor
$600K
Close Date
N/A
Total Funding
$600K
Expected Awards
1
Cost Sharing Required
No
Grants.gov ID
sbir-75N93025C00022
Description
SBIR Phase Phase I award: "B-SMART - BROADLY NEUTRALIZING ANTIBODIES FOR SARNA MEDIATED ANTIVIRAL RESPONSE THERAPY" awarded to LYNNTECH INC. in COLLEGE STATION, Texas. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $599,989. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.